Correction to Drug Makers Find 'Branded Generics' Are a Source for Growth Story
October 23 2017 - 11:18AM
Dow Jones News
Abbott's head of innovation and development for the emerging
markets is called Todd Chermak. "Drug Makers Find 'Branded
Generics' Are a Source for Growth," at 1210 GMT incorrectly stated
his surname as Todd Chermark in the 24th paragraph.
(END) Dow Jones Newswires
October 23, 2017 11:03 ET (15:03 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Sep 2023 to Sep 2024